You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 124 No. 1, January 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  Vignettes
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (11)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Persistent Cutaneous Reaction to Intramuscular Vitamin K Injection

John P. Joyce, MD; Antoinette F. Hood, MD; Margaret M. Weiss, MD
Department of Dermatology Johns Hopkins Hospital 600 N Wolfe St, Blalock 913-F Baltimore, MD 21205

Arch Dermatol. 1988;124(1):27-28.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Skin reactions to vitamin K have been previously described in the French and British literature.1-5 There are only two patients with a delayed cutaneous reaction at the site of intramuscular injection of phytonadione described in the American literature.6,7 We discuss two additional cases of skin reactions to intramuscular vitamin K injections.

Report of Cases.— CASE 1.—

In June 1981, a 36-year-old woman who was receiving long-term warfarin therapy following mitral valve commissurotomy presented with gastrointestinal and vaginal bleeding. She had received two intramuscular injections of vitamin K1 in her left lateral deltoid area. The injections, which were given one week apart, were in the form of phytonadione, an aqueous colloidal solution of vitamin K1. Approximately two weeks after the second injection, she developed a pruritic eruption at the injection sites. Oral antihistamines and intralesional corticosteroid injections were administered without significant symptomatic improvement. . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.